Connect to other sites within the UBM Medica Network
Anticoagulation for Atrial Fibrillation: Brief 3 Q and A
Catch up on current guideline recommendations in this quick question and answer with Kaiser Permanente cardiologist Payal Kohli, MD.
Drivers with Atrial Fibrillation Proceed with Caution
Drivers with AF hospitalized after a car accident are at greater risk of death than those without AF. Who gets a red light?
Sex Differences in AF: Find out What you Know
Is prevalence of atrial fibrillation higher in men or women? Which sex is more likely to be asymptomatic? At higher risk for stroke?
Ablation Therapy for Atrial Fibrillation: What's Your AQ?
Ablation has become a leading option to arrest AF in many patients. Try 3 quick questions to test your ablation quotient.
HOPE-3: Blood Pressure Lowering Alone Fails to Deliver For Some
Although results of the hypertension portion of HOPE-3 were disappointing, many caveats are offered to explain the outcome.
Management of AF Patients with Prior ICH – Race Specific Recommendations for High-Risk Patients
Results of a large Taiwanese registry analysis could open discussion around avoidance of oral anticoagulants in post-ICH patients.
New Analyses Only Partly Defuse ROCKET-AF Trial Concerns
Critics continue to call for independent analysis by outside investigators not involved with the original trial.
12 Bits On Chocolate and Health
Is eating chocolate good for your patients’ health or bad? Savor these slides for a concise summary of this favorite food’s medicinal pros and cons.
Cardiology Update: 6 New Things From ACP
It’s time to rethink aspirin; there’s optimism about the PCSK9 inhibitors; and new help for people with valvular heart disease. What else is new in cardiology?
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
Atrial Fibrillation: More Than an Electrical Problem
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
By clicking Accept, you agree to become a member of the UBM Medica Community.